Abstract
This study was designed to determine whether incorporation of γ-tocotrienol or α-tocopherol in an atherogenic diet would reduce the concentration of plasma cholesterol, triglycerides and fatty acid peroxides, and attenuate platelet aggregability in rats. For six weeks, male Wistar rats (n=90) were fed AIN76A semisynthetic test diets containing cholesterol (2% by weight), providing fat as partially hydrogenated soybean oil (20% by weight), menhaden oil (20%) or corn oil (2%). Feeding the ration with menhaden oil resulted in the highest concentrations of plasma cholesterol, low and very low density lipoprotein cholesterol, triglycerides, thiobarbituric acid reactive substances and fatty acid hydroperoxides. Consumption of the ration containing γ-tocotrienol (50 μ/kg) and α-tocopherol (500 mg/kg) for six weeks led to decreased plasma lipid concentrations. Plasma cholesterol, low and very low density lipoprotein cholesterol, and triglycerides each decreased significantly (P<0.001). Plasma thiobarbituric acid reactive substances decreased significantly (P<0.01), as did the fatty acid hydroperoxides (P<0.05), when the diet contained both chromanols. Supplementation with γ-tocotrienol resulted in similar, though quantitatively smaller, decrements in these plasma values. Plasma α-tocopherol concentrations were lowest in rats fed menhaden oil without either chromanol. Though plasma α-tocopherol did not rise with γ-tocotrienol supplementation at 50 mg/kg, γ-tocotrienol at 100 mg/kg of ration spared plasma α-tocopherol, which rose from 0.60±0.2 to 1.34±0.4 mg/dL (P<0.05). The highest concentration of α-tocopherol was measured in plasma of animals fed a ration supplemented with α-tocopherol at 500 mg/kg. In response to added collagen, the partially hydrogenated soybean oil diet without supplementary cholesterol led to reduced platelet aggregation as compared with the cholesterol-supplemented diet. However, γ-tocotrienol at a level of 50 mg/kg in the cholesterol-supplemented diet did not significantly reduce platelet aggregation. Platelets from animals fed the menhaden oil diet released less adenosine triphosphate than the ones from any other diet group. The data suggest that the combination of γ-tocotrienol and α-tocopherol, as present in palm oil distillates, deserves further evaluation as a potential hypolipemic agent in hyperlipemic humans at atherogenic risk.
Similar content being viewed by others
Abbreviations
- AIN:
-
American Institute of Nutrition
- ATP:
-
adenosine triphosphate
- chol:
-
cholesterol
- CO:
-
corn oil
- vitamin E:
-
α-tocopherol
- EDTA:
-
ethylenediaminetetraacetic acid
- HDL:
-
high density lipoprotein
- HMG-CoA:
-
3-hydroxy-3-methyl-glutaryl coenzyme A
- HPLC:
-
high-performance liquid chromatography
- LDL:
-
low density lipoprotein
- LOPS:
-
fatty acid hydroperoxides
- MO:
-
menhaden oil
- SO:
-
partially hydrogenated soybean oil
- TBARS:
-
thiobarbituric acid reactive substances
- TG:
-
triglycerides
- VLDL:
-
very low density lipoprotein
References
Hegsted, D.M., McGandy, R.B., Myers, M.L., and Stare, F.L. (1965)Am. J. Clin. Nutr. 17, 281–295.
Musch, K., Ojakian, M., and Williams, M.A. (1974)Biochim. Biophys. Acta 337, 343–348.
Dyerberg, J., and Bang, H.O. (1979)Lancet 2, 433–435.
Simopoulos, A.P. (1991)Am. J. Clin. Nutr. 54, 438–463.
Hwang, D., and Carrol, A. (1980)Am. J. Clin. Nutr. 35, 590–597.
Eskin, N.A.M. (1998)Canola Council 60, 17.
Rand, M.L., Hennison, A.A., and Hornstra, G. (1986)Atherosclerosis 62, 267–276.
Lenz, P., Watkins, T., and Bierenbaum, M. (1991)Thromb. Res. 61, 213–224.
Gey, K.F., Puska, P., Jordan, P., and Moser, U.K. (1991)Am. J. Clin. Nutr. 53, 326S-334S.
Steinberg, D. (1991)Circulation 84, 1420–1425.
Qureshi, A.A., Qureshi, N., Hasler-Rapacz, J.O., Weber, F.E., Chaudhary, V., Crneshaw, T.D., Gapor, A., Ong, A.S.H., Chong, Y.h., Peterson, D., and Rapacz, J. (1991)Am. J. Clin. Nutr. 53, 1042S-1049S.
Qureshi, A.A., Qureshi, N., Wright, J.J.K., Shen, Z., Kramer, G., Gapor, A., Chong, Y.H., Dewitt, G., Ong, A.S.H., Peterson, D.M., and Bradlow, B.A. (1991)Am. J. Clin. Nutr. 53, 1021S-1026S.
Wahlquist, M., Bogetic, Z., Quist, R., Lo, S., and Gan, T.E. (1991)Proceedings of PORIM Conference, p. 177, Palm Oil Research Institute of Malaysia, Kuala Lumpur.
Mihara, M., Uchiyama, M., and Fukuzawa, K. (1980)Biochem. Med. 23, 302–311.
Ohishi, N., Ohkawa, H., Miike, A., Tatano, T., and Yagi, K. (1985)Biochem. Intl. 10, 205–211.
Bieri, J.G., Tolliver, T.J., and Catigniani, C.L. (1979)Am. J. Clin. Nutr. 32, 2143–2149.
Galvez, A., Badimon, L., Badimon, J., and Fuster, V. (1986)Thromb. and Hem. 56, 128–132.
Mackie, I.J., Jones, R., Machin, S.J. (1984)J. Clin. Pathol. 37, 874–878.
Lichtenstein, A.H., Ausman, L.M., Carrasco, W., Jenner, J.L., Ordovas, J.M., and Schaefer, E.J. (1993)Arterioscler. and Thromb. 13, 154–169.
Haglund, O., Luostarinen, R., Wallin, R., Wibell, L., and Saldeen, T. (1991)J. Nutr. 121, 165–169.
Watkins, T., Lenz, P., and Bierenbaum, M. (1990)Thromb. Res. 59, 619–628.
Qureshi, A.A., Burger, W.C., Peterson, D.M., and Elson, C.E. (1986)J. Biol. Chem. 261, 1044–1050.
Pearce, B.C., Parker, R.A., Deason, M.E., Qureshi, A.A., and Wright, J.J.K. (1992)J. Med. Chem. 35, 3595–3606.
Lovastatin Study Group III (1988)J. Am. Med. Assoc. 260, 359–366.
Tan, D.S., Khor, H.T., Low, W.H.S., Ali, A., and Gapor, A. (1991)Am. J. Clin. Nutr. 53, 1027S-1030S.
Riemersma, R.A., Wood, D.A., Macintyre, C.C.A., Elton, R.A., Gey, K.F., and Oliver, M.F. (1991)Lancet 337, 1–5.
Bierenbaum, M.L., Noonan, F.J., Machlin, L.J., Machlin, S., Stier, A., Watson, P.B., Naso, A.M., and Fleischman, A.I. (1985)Nutr. Reports Intl. 31, 1171–1180.
Author information
Authors and Affiliations
About this article
Cite this article
Watkins, T., Lenz, P., Gapor, A. et al. γ-tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids 28, 1113–1118 (1993). https://doi.org/10.1007/BF02537079
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02537079